Lipids are a group of fats that are critical components of cells. They also provide energy. Lipid profile is often recommended as a part of cardiac risk assessment. It enables medical professionals to determine a person’s risk of heart disease. Present day blood lipids detectors analyze four principal lipid quotients. These include total cholesterol levels, triglycerides, low-density lipoprotein cholesterol (LDL) and high-density lipoprotein cholesterol (HDL). They are mainly used to diagnose atherosclerosis – an important indicator of cardiovascular diseases. —
Atherosclerosis refers to a condition in which plague builds up inside human arteries. This plague consists of cholesterol, fat, calcium, and various other components of blood. This is dangerous, as over a period, the plague hardens and narrows the arteries. Atherosclerosis leads to stroke, heart attack, and death.
Browse Full Research Report With TOC: https://www.radiantinsights.com/research/global-blood-lipids-detector-consumption-industry-2016
High risk factors associated with negative lipid levels are on the rise across the world. This will drive the blood lipids detector consumption industry in the near future. Certain conditions adversely affect test results. These include intake of food 9 to 12 hours before the test, pregnancy, liver disease, or alcohol and drug abuse. Medicines like diuretics, birth control pills, antibiotics, and corticosteroids can also give misleading results.
North America, Europe, and Asia are the main geographical segments of the global blood lipids detector consumption industry. Main countries contributing to the industry’s growth are the United States, Germany, Japan, and China.
See More Reports of This Category by Radiant Insights: https://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare
Asia is expected to play an important role in propelling the worldwide growth. Burgeoning populations of India and China and the rising incidences of various diseases are the main reasons. First-world regions account for a significant portion of the total market at present. They are characterized by huge populations suffering from elevated cholesterol levels owing to unhealthy lifestyles, lack of exercise, diabetes, stress, obesity, and excessive intake of junk food and alcohol. Smoking is another habit commonly prevalent in these regions.
A sophisticated healthcare system, higher awareness of patients regarding the risks associated with high levels of blood lipids, and a wide availability of quality products for detection are important factors triggering growth of the industry in North America and Europe. Moreover, a well-evolved medical reimbursement system also triggers adoption in these regions.
Leading global players include Siemens Diagnostics, Abbott Diagnostics, Bayer, Alere, Roche Diagnostics, and Omron.
Request A Sample Copy Of This Report at: https://www.radiantinsights.com/research/global-blood-lipids-detector-consumption-industry-2016/request-sample
About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Name: Michelle Thoras
Email: Send Email
Organization: Radiant Insights, Inc
Address: 28 2nd Street, Suite 3036, San Francisco, CA 94105, United States
Release ID: 127276